Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 2
2009 2
2010 3
2011 3
2012 1
2013 3
2014 4
2015 2
2016 5
2017 1
2018 2
2019 4
2020 2
2021 2
2022 8
2023 8
2024 11
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
Cheng Y, Han L, Wu L, Chen J, Sun H, Wen G, Ji Y, Dvorkin M, Shi J, Pan Z, Shi J, Wang X, Bai Y, Melkadze T, Pan Y, Min X, Viguro M, Li X, Zhao Y, Yang J, Makharadze T, Arkania E, Kang W, Wang Q, Zhu J; ASTRUM-005 Study Group. Cheng Y, et al. JAMA. 2022 Sep 27;328(12):1223-1232. doi: 10.1001/jama.2022.16464. JAMA. 2022. PMID: 36166026 Free PMC article. Clinical Trial.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Jun 20;42(18):2149-2160. doi: 10.1200/JCO.23.01500. Epub 2024 Mar 27. J Clin Oncol. 2024. PMID: 38537155 Free PMC article. Clinical Trial.
Netrin-1 in cancer: Potential biomarker and therapeutic target?
Kefeli U, Ucuncu Kefeli A, Cabuk D, Isik U, Sonkaya A, Acikgoz O, Ozden E, Uygun K. Kefeli U, et al. Among authors: cabuk d. Tumour Biol. 2017 Apr;39(4):1010428317698388. doi: 10.1177/1010428317698388. Tumour Biol. 2017. PMID: 28443497 Free article. Review.
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study.
Beypınar İ, Demir H, Yaslıkaya Ş, Köşeci T, Demir B, Çolak G, Ağaoğlu AB, Şahbazlar M, Şancı PC, Çabuk D, Işık U, Şahin E, Coşkun A, Caner B, Aykut T, Artaç M, Duygulu ME, Sever N, Öksüz S, Turan N, Aykan MB, Tüzün EK, Uysal M, Uğurlu İ, Sakin A, Acar C, Özaşkın D, Şakalar T, Keskinkılıç M, Yavuzşen T, Köse N, Ertürk İ, Yıldırım N, Balçık OY, Alkan A, Selvi O, Erçin E, Ünal OÜ, Karaçin C. Beypınar İ, et al. Among authors: cabuk d. Breast Cancer Res Treat. 2024 Dec;208(3):597-604. doi: 10.1007/s10549-024-07456-x. Epub 2024 Aug 9. Breast Cancer Res Treat. 2024. PMID: 39123071
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Kahraman S, Erul E, Gumusay O, Guven DC, Aksoy S, Basaran G, Seyyar M, Sahin E, Cabuk D, Bayram E, Paydas S, Demirel BC, Yaren A, Gulbagci B, Hacibekiroglu I, Baytemur NK, Demirci U, Davarci SE, Demir H, Mocan EE, Dogan O, Cilbir E, Yasar A, Bayoglu IV, Hizal M, Kayikcioglu E, Cetin B, Acar O, Erdogan AP, Keskinkilic M, Yavuzsen T, Unal OU, Yilmaz F, Dogan M, Orhan SO, Cubukcu E, Erol C, Sakalar T, Dulgar O, Karakas Y, Ozkanli G, Duman BB, Isik D, Karaoglanoglu M, Okutur SK, Yildirim N, Aydin E, Uluc BO, Keser M, Bilgin B, Aksoy A, Eren O, Kalkan NO, Er MM, Yucel H, Sunar V, Paksoy N, Aydin D, Turhal NS, Menekse S, Kut E, Aykan MB, Ozdemir O, Ozcelik M, Iriagac Y, Selcukbiricik F, Inal A, Karadurmus N, Akinci MB, Sendur MAN. Kahraman S, et al. Among authors: cabuk d. Clin Breast Cancer. 2025 Jul;25(5):e635-e644. doi: 10.1016/j.clbc.2025.03.003. Epub 2025 Mar 4. Clin Breast Cancer. 2025. PMID: 40190010
Is there a survival processing effect in metacognition?
Çabuk D, Yelimlieş A, Akçay Ç, Eskenazi T. Çabuk D, et al. Psychol Res. 2023 Sep;87(6):1981-1994. doi: 10.1007/s00426-022-01782-9. Epub 2022 Dec 29. Psychol Res. 2023. PMID: 36580145 Free PMC article.
Primary synovial sarcoma of lung.
Cabuk D, Ustuner B, Akgul AG, Acikgoz O, Yaprak B, Uygun K, Topcu S, Muezzinoglu B. Cabuk D, et al. Korean J Thorac Cardiovasc Surg. 2014 Jun;47(3):306-9. doi: 10.5090/kjtcs.2014.47.3.306. Epub 2014 Jun 5. Korean J Thorac Cardiovasc Surg. 2014. PMID: 25207234 Free PMC article.
Major and minor salivary gland cancers: A multicenter retrospective study.
Hacioglu MB, Erdogan B, Bardakcı M, Algın E, Gulbagcı B, Hacibekiroglu I, Hamdard J, Olmez OF, Akkus H, Oksuzoglu B, Goksu SS, Dae SA, Sumbul AT, Ugraklı M, Karaagac M, Sahin E, Cabuk D, Ozer O, Yavuzsen T, Arıkan R, Köstek O, Atcı MM, Sakin A, Deligonul A, Bayır D, Dincer M, Unsal O, Yazıcı O, Zeynelgil E, Gulmez A, Harputluoglu H, Erol C, Sendur MAN, Aytekin A, Akagunduz B, Oner I, Er O, Oztosun B, Gumus M, Selçukbiricik F, Aykan MB, Karadurmus N, Degerli E, Demirci NS, Turkmen E, Şakalar T, Secmeler S, Tanrıverdi O, Alkan A, Kemal Y, Cil I, Unal C, Iriagaç Y, Alan O, Balli S, Urun Y, Ozcan E, Turhal NS, Cicin I. Hacioglu MB, et al. Among authors: cabuk d. Head Neck. 2023 Jul;45(7):1643-1653. doi: 10.1002/hed.27376. Epub 2023 Apr 21. Head Neck. 2023. PMID: 37084179
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study.
Akturk Esen S, Seven I, Akdere Ates G, Colak R, Kinikoglu O, Akay Hacan B, Bakkal Temi Y, Sever N, Kahraman S, Arak H, Topcu A, Saray S, Akbas S, Beypinar İ, Acar O, Erdoğan AP, Yilmaz M, Isik D, Ates O, Cabuk D, Sendur MAN, Uncu D. Akturk Esen S, et al. Among authors: cabuk d. Anticancer Drugs. 2025 Aug 1;36(7):575-582. doi: 10.1097/CAD.0000000000001717. Epub 2025 Apr 1. Anticancer Drugs. 2025. PMID: 40162996
65 results